|
|
||||||||||||||||||
|
|
||||||||||||||||||
|
|||||||||||
PerCP contained in this product is protected by patents owned by Becton, Dickinson & Company (European patent 0314406, or Japanese Patent JP1888759). This product will not be sold or shipped to customers in France, Germany, Italy, United Kingdom or Japan until the pertinent patents are no longer in effect (October 21, 2008). Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe HTA125 monoclonal antibody reacts with human Toll-like receptor 4 (TLR4). So far, at least ten members of the Toll family have been identified in humans. This family of type I transmembrane proteins is characterized by an extracellular domain with leucine-rich repeats and a cytoplasmic domain with homology to the type I IL-1 receptor. Two of these receptors, TLR2 and TLR4, are pattern recognition receptors and signaling molecules in response to bacterial lipoproteins and have been implicated in innate immunity and inflammation. TLR4 physically associates with another molecule called MD-2, and together with CD14, this complex is responsible for LPS recognition and signaling. TLR4 is expressed by peripheral blood monocytes. HTA125 has been reported to immunoprecipitate human TLR4 (~100 kDa) from transfected cells. Most TLR cell surface expression, especially TLR1 and TLR4, occurs at low levels on monocytes and at even lower levels on other cell types including granulocytes and immature dendritic cells (iDC). Furthermore, a relatively high degree of variability in TLR surface expression has been reported among normal donors. For more information about detection of TLRs by flow cytometric analysis, please visit our website at http://www.ebioscience.com/ebioscience/appls/TLR_FC.htm. Applications ReportedFor research use only, not for diagnostic or therapeutic use. This HTA125 antibody has been reported for use in flow cytometric analysis. Applications TestedThis HTA125 antibody has been pre-titrated and tested by flow cytometric analysis of human peripheral blood cells. This can be used at 20 μl (1 μg) per million cells in a 100 μl total staining volume. References
Tabeta, K., K. Yamazaki, et al. 2000. Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun. 68(6): 3731-5. Akashi, S., H. Ogata, et al. 2000. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun. 268(1): 172-7. Shimazu, R., S. Akashi, et al. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 189(11): 1777-82. de Graaf R, Kloppenburg G, et al. 2006. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect. 8(7):1859-65. (HTA125, IHC paraffin, PubMed) Mirlashari MR and Lyberg T. 2003. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Med Sci Monit. 9(8):BR316-24. (HTA125, FA, PubMed) Related ProductsCat. 45-4724 PerCP-Cy5.5 Mouse IgG2a, K Isotype Control |
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |